Pacific Biosciences Of California Debt to Equity Ratio 2009-2020 | PACB

Current and historical debt to equity ratio values for Pacific Biosciences Of California (PACB) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Pacific Biosciences Of California debt/equity for the three months ending March 31, 2020 was 0.96.
Pacific Biosciences Of California Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2020-03-31 $0.04B $0.06B 0.68
2019-12-31 $0.04B $0.06B 0.76
2019-09-30 $0.04B $0.05B 0.84
2019-06-30 $0.04B $0.08B 0.58
2019-03-31 $0.05B $0.10B 0.47
2018-12-31 $0.02B $0.11B 0.13
2018-09-30 $0.01B $0.13B 0.11
2018-06-30 $0.01B $0.09B 0.17
2018-03-31 $0.01B $0.10B 0.14
2017-12-31 $0.01B $0.09B 0.16
2017-09-30 $0.01B $0.10B 0.10
2017-06-30 $0.01B $0.12B 0.09
2017-03-31 $0.01B $0.07B 0.19
2016-12-31 $0.02B $0.09B 0.19
2016-09-30 $0.02B $0.10B 0.16
2016-06-30 $0.02B $0.11B 0.14
2016-03-31 $0.02B $0.09B 0.17
2015-12-31 $0.02B $0.07B 0.20
2015-09-30 $0.02B $0.04B 0.36
2015-06-30 $0.02B $0.03B 0.43
2015-03-31 $0.01B $0.04B 0.35
2014-12-31 $0.01B $0.06B 0.26
2014-09-30 $0.01B $0.05B 0.26
2014-06-30 $0.01B $0.06B 0.23
2014-03-31 $0.01B $0.08B 0.18
2013-12-31 $0.01B $0.07B 0.19
2013-09-30 $0.01B $0.08B 0.16
2013-06-30 $0.01B $0.10B 0.13
2013-03-31 $0.02B $0.11B 0.14
2012-12-31 $0.00B $0.11B 0.00
2012-09-30 $0.00B $0.13B 0.02
2012-06-30 $0.00B $0.15B 0.02
2012-03-31 $0.00B $0.17B 0.02
2011-12-31 $0.00B $0.19B 0.02
2011-09-30 $0.00B $0.21B 0.02
2011-06-30 $0.00B $0.23B 0.02
2011-03-31 $0.00B $0.25B 0.01
2010-12-31 $0.00B $0.28B 0.01
2010-09-30 $0.00B $0.10B 0.02
2010-06-30 $0.00B $0.00B 0.00
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B $0.00B 0.00
2008-12-31 $0.00B $0.11B 0.01
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.730B $0.091B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $163.905B 31.11
Intuitive Surgical (ISRG) United States $80.262B 72.12
Edwards Lifesciences (EW) United States $47.837B 42.74
DexCom (DXCM) United States $42.194B 145.45
IDEXX Laboratories (IDXX) United States $32.470B 72.17
ALCON INC (ALC) Switzerland $30.239B 33.85
Olympus (OCPNY) Japan $26.047B 67.86
Fresenius Medical Care AG KGaA (FMS) Germany $25.615B 16.51
Hologic (HOLX) United States $17.753B 26.57
Teleflex (TFX) United States $17.374B 34.27
Varian Medical Systems (VAR) United States $15.785B 43.46
Sysmex ADR (SSMXY) Japan $15.570B 0.00
SONOVA HOLDING (SONVY) Switzerland $14.875B 0.00
ABIOMED (ABMD) United States $14.002B 83.55
STERIS (STE) Ireland $13.101B 26.96
Masimo (MASI) United States $11.928B 62.20
SARTORIUS AG (SARTF) Germany $10.777B 92.65
Penumbra (PEN) United States $8.456B 1377.65
Tandem Diabetes Care (TNDM) United States $6.343B 0.00
Globus Medical (GMED) United States $5.552B 44.46
Nevro (NVRO) United States $4.840B 0.00
Elekta AB (EKTAY) Sweden $4.267B 32.85
Integra LifeSciences Holdings (IART) United States $4.080B 18.71
Wright Medical Group (WMGI) Netherlands $3.903B 0.00
OPKO Health (OPK) United States $3.771B 0.00
Nihon Kohden (NHNKY) Japan $2.950B 29.86
LivaNova (LIVN) United Kingdom $2.311B 23.51
Cantel Medical (CMD) United States $2.202B 25.48
Integer Holdings (ITGR) United States $2.134B 16.16
Glaukos (GKOS) United States $1.922B 0.00
ShockWave Medical (SWAV) United States $1.684B 0.00
Veracyte (VCYT) United States $1.636B 0.00
Silk Road Medical (SILK) United States $1.577B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.489B 33.48
Luminex (LMNX) United States $1.486B 139.39
Mesa Laboratories (MLAB) United States $1.285B 63.43
GenMark Diagnostics (GNMK) United States $1.150B 0.00
OrthoPediatrics (KIDS) United States $0.968B 0.00
Accelerate Diagnostics (AXDX) United States $0.857B 0.00
CryoLife (CRY) United States $0.797B 351.00
Inogen (INGN) United States $0.770B 81.16
Tactile Systems Technology (TCMD) United States $0.729B 625.83
Intersect ENT (XENT) United States $0.691B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.667B 82.67
Natus Medical (NTUS) United States $0.608B 24.60
Si-Bone (SIBN) United States $0.576B 0.00
Quotient (QTNT) Switzerland $0.548B 0.00
Fluidigm (FLDM) United States $0.538B 0.00
AxoGen (AXGN) United States $0.486B 0.00
ViewRay (VRAY) United States $0.482B 0.00
Alphatec Holdings (ATEC) United States $0.435B 0.00
Vermillion (AWH) United States $0.432B 0.00
SeaSpine Holdings (SPNE) United States $0.408B 0.00
Repro Med Systems (KRMD) United States $0.389B 177.20
TransMedics (TMDX) United States $0.386B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.363B 0.00
AngioDynamics (ANGO) United States $0.355B 104.78
Semler Scientific (SMLR) United States $0.336B 43.07
IRadimed (IRMD) United States $0.268B 50.95
Accuray (ARAY) United States $0.236B 0.00
Sientra (SIEN) United States $0.210B 0.00
T2 Biosystems (TTOO) United States $0.203B 0.00
Restoration Robotics (VERO) Canada $0.098B 0.00
EDAP TMS S.A (EDAP) France $0.095B 46.86
Spectral Diagnostics (EDTXF) Canada $0.092B 0.00
Neuronetics (STIM) United States $0.066B 0.00
DarioHealth (DRIO) Israel $0.066B 0.00
MRI Interventions (CLPT) United States $0.062B 0.00
Bioanalytical Systems (BASI) United States $0.056B 0.00
ConforMIS (CFMS) United States $0.055B 0.00
Ekso Bionics Holdings (EKSO) United States $0.052B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.051B 0.00
Sensus Healthcare (SRTS) United States $0.050B 0.00
Delcath Systems (DCTH) United States $0.049B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.043B 0.00
Allied Healthcare Products (AHPI) United States $0.042B 0.00
Apollo Endosurgery (APEN) United States $0.036B 0.00
Sunshine Heart Inc (CHFS) United States $0.031B 0.00
Neovasc (NVCN) Canada $0.030B 0.00
Avinger (AVGR) United States $0.029B 0.00
ReWalk Robotics (RWLK) Israel $0.025B 0.00
Helius Medical Technologies (HSDT) United States $0.022B 0.00
Second Sight Medical Products (EYES) United States $0.021B 0.00
ENDRA Life Sciences (NDRA) United States $0.016B 0.00
Dynatronics (DYNT) United States $0.013B 0.00
Viveve Medical (VIVE) United States $0.009B 0.00
Lianluo Smart (LLIT) China $0.009B 0.00
Nanovibronix (NAOV) United States $0.007B 0.00
OBALON THERPTCS (OBLN) United States $0.006B 0.00
Ra Medical Systems (RMED) United States $0.005B 0.00